We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amphastar is suing the FDA for detaining two shipments of raw heparin, saying the holdup is part of a pattern of arbitrary regulatory treatment and has delayed the approval of its generic version of the blood thinner Lovenox.